Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Topical t-PA for the treatment of venous ulcers

July 2, 1997

No Comments

Synthesis and pharmacological profile of new antithrombotic pentasaccharide

July 2, 1997

No Comments

Cell Genesys reports encouraging preclinical results of gene therapy for hemophilia

July 1, 1997

No Comments

ReoPro safe and effective in high-risk PTCA patients

July 1, 1997

No Comments

Modified t-PA from Eisai highly effective thrombolytic

July 1, 1997

No Comments

TIMI-IIA finds enoxaparin promising

July 1, 1997

No Comments

New indication for enoxaparin recommended for approval

June 27, 1997

No Comments

Thrombin inhibitors from Akzo Nobel

June 27, 1997

No Comments

Orally active antithrombotic agents described by Pfizer

June 27, 1997

No Comments

S.c. lepirudin vs. i.v. heparin for deep vein thrombosis

June 23, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

Topical t-PA for the treatment of venous ulcers

Synthesis and pharmacological profile of new antithrombotic pentasaccharide

Cell Genesys reports encouraging preclinical results of gene therapy for hemophilia

ReoPro safe and effective in high-risk PTCA patients

Modified t-PA from Eisai highly effective thrombolytic

TIMI-IIA finds enoxaparin promising

New indication for enoxaparin recommended for approval

Thrombin inhibitors from Akzo Nobel

Orally active antithrombotic agents described by Pfizer

S.c. lepirudin vs. i.v. heparin for deep vein thrombosis

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

Hematologic RSS

Hematologic
RSS